Biopharmaceutical companies experienced a continued decrease in layoffs during the third quarter of 2026. This trend suggests the sector is recovering from the significant job cuts seen in the previous year. While one large company disclosed substantial layoffs, the overall number of announcements remained low. Recruiters are observing positive signs indicating an upward trajectory for the industry. Demand for talent is persisting, with new roles emerging, particularly those incorporating AI skills.
New Jersey
https://www.fiercebiotech.com/biotech/biopharma-recruiters-seeing-signs-recovery-layoffs-stay-cool-q326